Skip to main content
Earnings Labs
Zentalis Pharmaceuticals, Inc. logo

Zentalis Pharmaceuticals, Inc. (ZNTL)

NASDAQ·Healthcare·Biotechnology

$3.76

+6.68%

Mkt Cap $260.54M

Analyst Ratings

Buy

2

Hold

0

Sell

0

Price Target (14 analysts)

$10.00

Range $10.00$10.00

Implied Upside

+166.3%

Consensus $10.00 vs current $3.76